April 2024 | Deals & Transactions
Conyers Advises NYSE Listed Nuvation Bio Inc. on its Acquisition of AnHeart Therapeutics Ltd.
April 2024 | Deals & Transactions
Conyers Advises NYSE Listed Nuvation Bio Inc. on its Acquisition of AnHeart Therapeutics Ltd.
March 2024 | Deals & Transactions
Conyers Advises Murano on its Merger with HCM Acquisition Corp
February 2024 | Deals & Transactions
Conyers advises Digicel on Bermuda schemes of arrangements pursuant to US$3.8 billion cross-border restructuring
December 2023 | Deals & Transactions
Conyers Advises Francisco Partners on Its Investment in the Combination of Muse Group and Hal Leonard
November 2023 | Deals & Transactions
Conyers Advises GLAAM and Captivision on Their Business Combination with Nasdaq-Listed Jaguar Global Growth Corporation I
November 2023 | Deals & Transactions
Conyers’ Cayman Islands and Bermuda Teams Advise LSE-Listed Financials Acquisition Corp on Its Proposed Business Combination with London Innovation Underwriters
May 2023 | Deals & Transactions
Conyers Advises Inflection Point Acquisition Corp. II on US$220 Million IPO
March 2023 | Deals & Transactions, News
Conyers Advises Murano on its Proposed Merger with HCM Acquisition Corp
March 2023 | Deals & Transactions, News
Conyers Advises Lexasure Financial Group Limited on its Proposed Merger with Nasdaq Listed Capitalworks Emerging Markets Acquisition Corp
Stay current with our latest legal insights: subscribe today